ReviewCureus2025

Comparative Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors Versus Glucagon-Like Peptide-1 Receptor Agonists in Reducing Cardiovascular Events in Patients With Type 2 Diabetes.

Hashmat Ullah Khan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.